A study reinforces the importance of supporting the arm and placing the BP cuff at heart level, as guidelines recommend.

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

The incidental mammogram finding isn’t a reason to panic, but it might a reason to make sure other risk factors are under ...

With a much longer half-life than other radiotracers, flurpiridaz F-18 will boost patient access to PET imaging, one expert ...

The randomized study lasted just 3 months, but researchers saw “multiple cardiometabolic benefits” beyond weight loss.

Two new analyses from HELIOS-B answer important questions, but some uncertainties remain, says Julie Rosenthal.

In one study, outcomes were similar regardless of baseline LVEF and recent worsening HF emerged as an important indicator.

Whether a drug that selectively targets fat mass, with modest weight loss, translates into CV benefits awaits further study.

Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.

Postmarket data on MitraClip lend further support to the idea that this subgroup fares as well as the overall SMR population.

While promising, questions remain about sustained long-term benefits of cardiac myosin inhibitors and their impact on ...

Most of our top stories this month stemmed from the ESC Congress—a mix of drug and device trials as well as guidelines.